Important notice regarding Inveltys

Posted in Latest News on August 7, 2019.

Important notice regarding Inveltys:

The board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002. Effective August 5, 2019, Licensees are now permitted to prescribe Inveltys.



More Latest News

2024 Bills Impacting Health Care Professions
May 1, 2024

Click here to view a full list of bill summaries from the 2024 Florida Legislative Session that may impact your profession. Continue reading


Announcement
December 14, 2023

MQA Online Services will be unavailable from Friday, December 15, at 6:00 PM to December 17, at 12:00 PM EST. Continue reading